Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8GWN

A mechanism for SARS-CoV-2 RNA capping and its inhibitor of AT-527

Summary for 8GWN
Entry DOI10.2210/pdb8gwn/pdb
EMDB information34317
DescriptorRNA-directed RNA polymerase, Non-structural protein 8, Non-structural protein 7, ... (9 entities in total)
Functional Keywordssars-cov-2, capping, nucleotide analogue inhibitor, cryo-em, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2
More
Total number of polymer chains9
Total formula weight325749.72
Authors
Yan, L.M.,Huang, Y.C.,Ge, J.,Liu, Z.Y.,Gao, Y.,Rao, Z.H.,Lou, Z.Y. (deposition date: 2022-09-17, release date: 2022-12-14, Last modification date: 2023-10-25)
Primary citationYan, L.,Huang, Y.,Ge, J.,Liu, Z.,Lu, P.,Huang, B.,Gao, S.,Wang, J.,Tan, L.,Ye, S.,Yu, F.,Lan, W.,Xu, S.,Zhou, F.,Shi, L.,Guddat, L.W.,Gao, Y.,Rao, Z.,Lou, Z.
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
Cell, 185:4347-4360.e17, 2022
Cited by
PubMed Abstract: Decoration of cap on viral RNA plays essential roles in SARS-CoV-2 proliferation. Here, we report a mechanism for SARS-CoV-2 RNA capping and document structural details at atomic resolution. The NiRAN domain in polymerase catalyzes the covalent link of RNA 5' end to the first residue of nsp9 (termed as RNAylation), thus being an intermediate to form cap core (GpppA) with GTP catalyzed again by NiRAN. We also reveal that triphosphorylated nucleotide analog inhibitors can be bonded to nsp9 and fit into a previously unknown "Nuc-pocket" in NiRAN, thus inhibiting nsp9 RNAylation and formation of GpppA. S-loop (residues 50-KTN-52) in NiRAN presents a remarkable conformational shift observed in RTC bound with sofosbuvir monophosphate, reasoning an "induce-and-lock" mechanism to design inhibitors. These findings not only improve the understanding of SARS-CoV-2 RNA capping and the mode of action of NAIs but also provide a strategy to design antiviral drugs.
PubMed: 36335936
DOI: 10.1016/j.cell.2022.09.037
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.38 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon